Clinical trialsRegistry-verifiedPrivate-market model

INTENSIFY MDD trial site — Medical University Innsbruck

Innsbruck, Austria

Treatment & access

Treatments offeredEsketamine (clinical trial) · IV ketamine (clinical trial)
Access routeTrial enrollment
Cost & coverage (registry status)no cost within trial
Websitehttps://clinicaltrials.gov/study/NCT05973851

Related listings

These records belong to the same organisation. They are listed separately because each is a distinct programme or location.

Location in CagliariINTENSIFY MDD trial site — University of Cagliari : Clinical trials
Location in NaplesINTENSIFY MDD trial site — Università degli Studi della Campania Luigi Vanvitelli : Clinical trials
Location in TurinINTENSIFY MDD trial site — AOU Città della Salute e della Scienza di Torino : Clinical trials
Location in BresciaINTENSIFY MDD trial site — Università degli Studi di Brescia : Clinical trials

About this provider

Compiled from the registry data on this page.

The INTENSIFY MDD substudy (Psych-STRATA), registered on ClinicalTrials.gov under NCT05973851, lists INTENSIFY MDD trial site: Medical University Innsbruck in Innsbruck, Austria, among its sites. This directory entry concerns esketamine and IV ketamine studied for major depressive disorder after first-time failure of first-line treatment; access runs through enrolment in the trial, at no cost within the trial. The registry listed the site status as RECRUITING on 2026-07-29. The ClinicalTrials.gov record is the registry source cited; last verification on 2026-07-29.

Services & programs

Programs & studies

Program	Kind	Status
Clinical trial (NCT05973851) Auto-linked from the record’s registry sources; status refreshed from ClinicalTrials.gov. Key entry criteria by protocol: age 18–65 · patients only (no healthy volunteers). Full inclusion and exclusion criteria on the registry. The research team makes the final eligibility decision.	clinical trial	Recruiting

Common questions

What does treatment cost at INTENSIFY MDD trial site — Medical University Innsbruck?

no cost within trial As published by the provider (verified 2026-07-29).

Is treatment at INTENSIFY MDD trial site — Medical University Innsbruck covered by insurance?

INTENSIFY MDD substudy (Psych-STRATA, Horizon Europe): 6-week intensified pharmacological treatment (oral AD + esketamine nasal/IV or ketamine IV) vs treatment as usual. Registry site status 2026-07-29: RECRUITING. (Verified 2026-07-29.)

Verification

License / registryPublic trial registry (ClinicalTrials.gov / EU CTIS)
Official registryhttps://clinicaltrials.gov/study/NCT05973851
Last verified2026-07-29

Re-checked every 90 days · how we verify and report corrections

Check your fit & enquire

Check my fit & enquire

Free 2-minute pre-screening in your browser · your summary goes only to INTENSIFY MDD trial site — Medical University Innsbruck, with your consent.

What to prepare before you enquire

A referral or the contact details of your treating clinician
A list of medications you have tried (names, doses, duration)
A short diagnosis summary or discharge letters

The research team confirms eligibility against your medical records at a screening visit.

Send documents directly to the provider when they reply. We never ask you to upload medical records.

Check my fit & enquire